Heterocyclic aromatic amines: Potential human carcinogens

Advances in Molecular Toxicology

Volumn 4, Issue C, 2010, Pages 37-83

  Turesky, Robert J ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; HETEROCYCLIC AMINE;

ARTICLE; CARCINOGENESIS; COOKED FOOD; DNA ADDUCT; DNA POLYMORPHISM; EXPOSURE; FISH; FOOD COMPOSITION; FOOD PROCESSING; GENE MUTATION; MEAT; MUTAGENESIS; NITROSATION; NONHUMAN; POULTRY; PRIORITY JOURNAL;

EID: 77954238847     PISSN: 18720854     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1872-0854(10)04002-6     Document Type: Chapter

References (243)

1. B.N. Ames, L.S. Gold, W.C. Willst, The causes and prevention of cancer, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 5258-5265.
2. T. Sugimura, N. Nagao, T. Kawachi, M. Honda, T. Yahagi, Y. Seino, S. Stao, N. Matsukura, T. Matsushima, A. Shirai, M. Sawamura, H. Matsumoto, Mutagencarcinogens in food, with special reference to highly mutagenic pyrolytic products in broiled foods, in: H.H. Hiatt, J.D. Watson, J.A. Winstein (Eds.), Origins of Human Cancer, Book C, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1977, pp. 1561-1577.
3. J.S. Felton, M. Jagerstad, M.G. Knize, K. Skog, K. Wakabayashi, Contents in foods, beverages and tobacco, in: M. Nagao, T. Sugimura (Eds.), Food. Borne Carcinogens Heterocyclic Amines, John Wiley & Sons Ltd., Chichester, England, 2000, pp 31-71.
4. K.I. Skog, M.A. Johansson, M.I. Jagerstad, Carcinogenic heterocyclic amines in model systems and cooked foods: A review on formation, occurrence and intake, Food Chem. Toxicol. 36 (1998) 879-896. (Pubitemid 28408707)
5. T. Sugimura, K. Wakabayashi, H. Nakagama, M. Nagao, Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish, Cancer Sci. 95 (2004) 290-299. (Pubitemid 38519467)
6. R.J. Turesky, A.K. Goodenough, W. Ni, L. McNaughton, D.M. LeMaster, R.D. Holland, R.W. Wu, J.S. Felton, Identification of 2-amino-1,7-dimethylimidazo[4, 5-gjquinoxaline: An abundant mutagenic heterocyclic aromatic amine formed in cooked beef, Chem, Res. Toxicol. 20 (2007) 520-530.
7. S. Manabe, S. Izumikawa, K. Asaku.no, O. Wada, Y. Kanai, Detection of carcinogenic amino-alpha-carbolines and amino-gamma-carbolines in diesel-exhaust particles, Environ, Pollut. 70 (1991) 255-265.
8. S. Manabe, K. Tohyama, O. Wada, T. Aramaki, Detection of a carcinogen, 2-amino-1 -methyl-6-phenylimidazo[4,5-b]pyridine, in cigarette smoke condensate, Carcinogenesis 12 (1991) 1945-1947.
9. G.A. Keating, K.T. Bogen, Estimates of heterocyclic amine intake in the US population, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 802 (2004) 127-133.
10. National Toxicology Program, Report on Carcinogenesis, Eleventh Edition, U.S. Department of Health and Human Services, Public Health Service, Research Triangle Park, N.C., 2005.
11. T. Sugimura., Multistep carcinogenesis: A 1992 perspective, Science 258 (1992) 603-607.
12. S. Manabe, O. Wada, Y. Kanai, Simultaneous determination of amino-alpha-carbolines and amino-gamma-carbolines in cigarette smoke condensate by high-performance liquid chromatography, J. Chromatogr. 529 (1990) 125-133.
13. D. Yoshida, T. Matsumoto, Amino-alpha-carbolines as mutagenic agents in cigarette smoke condensate, Cancer Lett. 10 (1980) 141-149. (Pubitemid 10012465)
14. S.S. Hecht, Tobacco carcinogens, their biomarkers and tobacco-induced cancer, Nat. Rev. Cancer 3 (2003) 733-744.
15. Z. Yamaizumi, T. Shiomi, H. Kasai, S. Nishimura, Y. Takahashi, M. Nagao, T. Sugimura, Detection of potent mutagens, Trp-P-1 and Trp-P-2, in broiled fish, Cancer Lett. 9 (1980) 75-83.
16. T. Matsumoto, D. Yoshida, H. Tomita, Determination of mutagens, amino-alphacarbolines in grilled foods and cigarette smoke condensate, Cancer Lett. 12 (1981) 105-110.
17. 32 P-postlabeIling analysis of DNA adducts, Z. Lebensm Unters Forsch A, 207 (1998) 472-476.
18. G.A. Gross, A. Gruter, Quantitation of mutagenic/carcinogenic heterocyclic aromatic amines in food products, J. Chromatogr. 592 (1992) 271-278.
19. K. Skog, K Augustsson, G. Steineck, M. Stenberg, M. Jagerstad, Polar and non-polar heterocyclic amines in cooked fish and meat products and their corresponding pan residues, Food Chem. Toxicol. 35 (1997) 555-565.
20. K. Skog, A. Solyakov, P. Arvidsson, M. Jagerstad, Analysis of nonpolar heterocyclic amines in cooked foods and meat extracts using gas chromatography-mass spectrometry, J. Chromatogr. A, 803 (1998) 227-233.
21. R.J. Turesky, J. Taylor, L. Schnackenberg, J.P. Freeman, R.D. Holland, Quantitation of carcinogenic heterocyclic aromatic amines and detection of novel heterocyclic aromatic amines in cooked meats and grill scrapings by HPLC/ESI-M.S, J. Agric. Food Chem. 53 (2005) 3248-3258.
22. M. Jagerstad, K. Skog, S. Grivas, K. Olsson, Formation of heterocyclic amines using model systems, Mutat. Res. 259 (1991) 219-233.
23. K. Skog, M. Jagerstad, Incorporation of carbon atoms from glucose into the food mutagens MeIQx and 4,8-DiMeIQx using 14C-labelled glucose in a model system, Carcinogenesis 14 (1993) 2027-2031.
24. B.L. Milic, S.M. Djilas, J.M. Candadanoic-Brunet, Synthesis of some heterocyclic aminoimidazoarenes, Food Chem, 46 (1993) 273-276.
25. M. Shioya, K. Wakabayashi, S. Sato, M. Nagao, T. Sugimura, Formation of a mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) in cooked beef, by heating a mixture containing creatinine, phenylalanine and glucose, Mutat. Res. 191 (1987) 133-138.
26. M. Murkovic, Formation of heterocyclic aromatic amines in model systems, J. Chromatogr. B. 802 (2004) 3-10. (Pubitemid 38224266)
27. A.M. Pearson, C. Chen, J.I. Gray, S.D. Aust, Mechanism(s) involved in meat mutagen formation and inhibition, Free Radic. Biol. Med. 13 (1992) 161-167.
28. T. Kato, T. Harashima, N. Moriya, K. Kikugawa, K. Hiramoto, Formation of the mutagenic/carcinogenic imidazoquinoxaline-type heterocyclic amines through, the unstable free radical. Maillard intermediates and its inhibition by phenolic antioxidants, Carcinogenesis 17 (1996) 2469-2476.
29. Y. Totsuka, H. Ushiyama, J. Ishihara, R. Sinha, S. Goto, T. Sugimura, K. Wakabayashi, Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods, Cancer Lett. 143 (1999) 139-143.
30. T. Totsuka, R. Nishigaki, T. Sugimura, K. Wakabayashi, The possible involvement of mutagenic and carcinogenic beteroyclic amines in human cancer, in: K. Skog, J. Alexander (Eds.), Acrylamide and Other Hazardous Compounds in Heat-Treated Foods, Woodhead Publisher, Boca Raton, Fl, 2006, pp. 296-515.
31. N. Hada, Y. Totsuka, T. Enya, K. Tsurumaki, M. Nakazawa, N. Kawahara, Y. Murakami, Y. Yokoyama, T. Sugimura, K. Wakabayashi, Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers, Mutat. Res. 493 (2001) 115-126.
32. Y. Oda, Y. Totsuka, K. Wakabayashi, F.P. Guengerich, T. Shimada, Activation of aminophenylnorharman, aminomethylphenylnorharman and ammophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains, Mutagenesis 21 (2006) 411-416.
33. R. Nishigaki, Y. Totsuka, T. Takamura-Enya, T. Sugimura, K. Wakabayashi, Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline, Mutat. Res. 562 (2004) 19-25.
34. T. Kawamori, Y. Totsuka, N. Uchiya, T. Kitamura, H. Shibata, T. Sugimura, K. Wakabayashi, Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats, Carcinogenesis 25 (2004) 1967-1972.
35. R. Nishigaki, Y. Totsuka, H. Kataoka, H. Ushiyama, S. Goto, T. Akasu, T. Watanabe, T. Sugimura, K. Wakabayashi, Detection of aminophenylnorharman, a possible endogenous mutagenic and carcinogenic compound, in human urine samples, Cancer Epidemiol. Biomarkers Prev. 16 (2007) 151-156.
36. E. Ronne, K. Olsson, S. Grivas, One-step synthesis of 2-amino-1-methylimidazo [4,5-6]quinoline, Synthetic Commun. 24 (1994) 1363-1366.
37. R. Vikse, F.T. Hatch, N.W. Winter, M.G. Knize, S. Grivas, J.S. Felton, Structuremutagenicity relationships of four amino-imidazonaphthyridines and imidazoquinolines, Environ. Mol. Mutagen 26 (1995) 79-85.
38. R.D. Holland, T. Gehring, J. Taylor, B.G. Lake, N.J. Gooderham, R.J. Turesky, Formation of a mutagenic heterocyclic aromatic amine from creatinine in urine of meat eaters and vegetarians, Chem Res. Toxicol. 18 (2005) 579-590.
39. K. Skog, Cooking procedures and food mutagens: A literature review, Food Chem, Toxicol. 31 (1993) 655-675.
40. K. Skog, A. Solyakov, Heterocyclic amines in poultry products: A literature review, Food Chem. Toxicol. 40 (2002) 1213-1221.
41. K. Skog, G. Steineck, K. Augustsson, M. Jagerstad Effect of cooking temperature on the formation of heterocyclic amines in fried meat products and pan residues, Carcinogenesis 16(1995) 861-867.
42. J.S. Felton, M.G. Knize, Heterocyclic amine mutagens/carcinogens in foods, in: C.S. Cooper, P.L. Grover (Eds.), Handbook of .Experimental Pharmacology, SpringerVerlag, Berlin Heidelberg, 1990, pp. 471-502.
43. M.G. Knize, F.A. Dolbeare, K.L. Carroll, D.H. Moore, J.S. Felton, Effect of cooking time and temperature on the heterocyclic amine content of fried beef patties, Food Chem. Toxicol. 32 (1994) 595-603.
44. R. Sinha, N. Rothman, C.P. Salmon, M.G. Knize, E.D. Brown, C.A. Swanson, D. Rhodes, S. Rossi, J.S. Felton, O.A. Levander, Heterocyclic amine content in beef cooked by different methods to varying degrees of doneness and gravy made from meat drippings, Food Chem, Toxicol, 36 (1998) 279-287.
45. R. Sinha, M.G. Knize, C.P. Salmon, E.D. Brown, D. Rhodes, J.S. Felton, O.A. Levander, N. Rothman, Heterocyclic amine content of pork products cooked by different methods and to varying degrees of doneness, Food Chem, Toxicol, 36 (1998) 289-297.
46. A. Solyakov, K. Skog, M. Jagerstad, Heterocyclic amines in process flavours, process flavour ingredients, bouillon concentrates and a pan residue, Food Chem Toxicol. 37 (1999) 1-11.
47. R. Sinha, N. Rothman, E.D. Brown, C.P. Salmon, M.G. Knize, C.S. Swanson, S.C. Rossi, S.D. Mark, O.A. Levander, J.S. Felton, High, concentrations of the carcinogen. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method, Cancer Res. 55 (1995) 4516-4519.
48. H. Nukaya, S. Koyota, F. Jinno, H. Ishida, K. Wakabayashi, R. Kurosaka, L.S. Kim, Z. Yamaizumi, H. Ushiyama, T. Sugimura, Structural determination of a new mutagenic heterocyclic amine, 2-amino-1,7,9-trimethylimidazo[4,5-g] quinoxaline (7,9-DiMeIgQx), present in beef extract, Carcinogenesis 15 (1994) 1151-1154.
49. F.T. Hatch, M.G. Knize, M.E. Colvin, Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: Structural, electronic, and hydropathic factors affecting mutagenic potency, Environ. Mol. Mutagen 38 (2001) 268-291.
50. R.J. Turesky, A. Constable, J. Richoz, N. Varga, J. Markovic, M.V. Martin, P.P. Guengerich, Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2, Chem. Res. Toxicol. 11 (1998) 925-936.
51. F.G. Crofts, T.R. Sutter, P.T. Strickland, Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501 A1, P4501A2 and P4501B1, Carcinogenesis 19 (1998) 1969-1973.
52. G.J. Hammons, D. Milton, K. Stepps, F.P. Guengerich, F.F. Kadlubar, Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes, Carcinogenesis 18 (1997) 851-854.
53. R.J. Turesky, P. Vouros, Formation and analysis of heterocyclic aromatic amineDNA adducts in vitro and in vivo, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 802 (2004) 155-166.
54. H.A. Schut, E.G. Snyderwine, DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis, Carcinogenesis 20 (1999) 353-368.
55. E.L. Jamin, D. Arquier, C. Canlet, E. Rathahao, J. Tulliez, L. Debrauwer, New insights in the formation of deoxynucleoside adducts with the heterocyclic aromatic amines PhIP and IQ by means of ion trap MSn and accurate mass measurement of fragment ions, J. Am. Soc. Mass Spectrom. 18 (2007) 2107-2118.
56. E.E. Bessette, A.K. Goodenough, S. Langouet, I. Yasa, I.D. Kozekov, S.D. Spivack, R.J. Turesky, Screening for DNA adducts by data-dependent constant neutral loss-triple stage mass spectrometry with a linear quadrupole ion trap mass spectrometer, Anal. Chem. 81 (2009) 809-819.
57. 2 atoms of guanine, Chem. Res. Toxicol. 5 (1992) 479-490.
58. G.R. Hoffmann, R, P. Fuchs, Mechanisms of frameshift mutations: Insight from aromatic amines, Chem Res. Toxicol, 10 (1997) 347-359. (Pubitemid 27176294)
59. S. Broyde, L. Wang, L. Zhang, O. Rechkoblit, N,E. Geacintov, D.J. Patel, DNA adduct structure-function relationships: Comparing solution with polymerase structures, Chem. Res. Toxicol. 21 (2008) 45-52.
60. J.C. Delaney, J.M, Essigmann, Biological properties of single chemical-DNA adducts: A twenty year perspective, Chem. Res. Toxicol, 21 (2008) 232-252.
61. X. Tan, N. Suzuki, A.P. Grollman, S. Shibutani, Mutagenic events in Escherichia coli and mammalian cells generated in response to acetylaminofluorene-derived DNA adducts positioned in. The Nar I restriction enzyme site, Biochemistry 41 (2002) 14255-14262.
62. J.Y. Choi, J.S. Stover, K.C. Angel, G. Chowdhury, C.J. Rizzo, F.P. Guengerich, Biochemical basis of genotoxicity of heterocyclic arylamine food mutagens: Human DNA polymerase eta selectively produces a two-base deletion in copying the N2guanyl adduct of 2-amino-3-methylimidazo[4,5-f]qumoline but not the CS adduct at the Narl G3 site, J. Biol. Chem. 281 (2006) 25297-25306.
63. J.S. Stover, G. Chowdhury, H. Zang, F.P. Guengerich, C.J. Rizzo, Translesion synthesis past the C8- and N2-deoxyguanosine adducts of the dietary mutagen 2-A.min.o-3-methyliniidazo[4,5-f]quinoline in the Narl recognition sequence by prokaryotic DNA polymerases, Chem. Res. Toxicol. 19 (2006) 1506-1517.
64. S. Shibutani, A. Fernandes, N. Suzuki, L. Zhou, F. Johnson, A.P. Grollman, Mutagenesis of the N-(deoxyguanosin-8-yl)-2-aniino-l-methyl-6- phenylimidazo[4,5-fo] pyridine DNA adduct in. mammalian cells. Sequence context effects, J. Biol, Chem, 274 (1999) 27433-27438.
65. S. Shibutani, N. Suzuki, A.P. Grollman, Mutagenic specificity of (acerylamino) fluorene-derived DNA adducts in mammalian cells, Biochemistry 37 (1998) 12034-12041. (Pubitemid 28411286)
66. K. Brown, B.E. Hingerty, E.A. Guenther, V.V. Krishnan, S. Broyde, K.W. Turteltaub, M. Cosman, Solution structure of the 2-amino-l-methyl-6- phenylimidazo [4,5-b]pyridine C8-deoxyguanosine adduct in. duplex DNA, Proc. Natl, Acad. Sd. U. S. A. 98 (2001) 8507-8512.
67. C.E. Elmquist, J.S. Stover, Z. Wang, C.J. Rizzo, Site-specific synthesis and properties of oligonucleotides containing C8-deoxyguanosine adducts of the dietary mutagen IQ, J. Am. Chem. Soc. 126 (2004) 11189-11201.
68. F. Wang, N.E. DeMuro, C.E. Elmquist, J.S. Stover, C.J. Rizzo, M.P. Stone, Basedisplaced intercalated structure of the food mutagen 2-amino-3- methylimidazo[4,5-f| quinoline in. The recognition sequence of the Narl restriction, enzyme, a hotspot for -2 bp deletions, J. Am. Chem. Soc. 128 (2006) 10085-10095.
69. D.J. Patel, B. Mao, Z. Gu, B.E. Hingerty, A. Gorin, A.K, Basu, S. Broyde, Nuclear magnetic resonance solution, structures of covalent aromatic amine-DNA adducts and their mutagenic relevance, Chem Res. Toxicol. 11 (1998) 391-407.
70. M. Lukin, S.C. de Los, NMR structures of damaged DNA, Chem. Rev. 106 (2006) 607-686.
71. T. Zaliznyak, R. Bonala, F.Johnson, S.C. de Los, Structure and stability of duplex DNA containing the 3-(deoxyguanosin-N2-yl)-2-acetylaminofluorene (dG(N2)-AAF) lesion: A bulky adduct that persists in cellular DNA, Chem. Res. Toxicol, 19 (2006)745-752.
72. S.J. Gulp, M.C. Poirier, F.A. Beland, Biphasic removal of DNA adducts in a repetitive DNA sequence after dietary administration of 2-acetylaminofluorene, Environ. Health Perspect. 99 (1993) 273-275.
73. R.J. Turesky, R.M. Box, J. Markovic, E. Gremaud, E.G. Snyderwine, Formation and persistence of DNA adducts of 2-amino-3-methyliniidazo[4,5-y] quinoline in the rat and nonhuman primates, Mutat. Res. 376 (1997) 235-241.
74. F.A. Belaud, F.F. Kadlubar, Formation and persistence of arylamine DNA adducts in vivo, Environ, Health Perspect. 62 (1985) 19-30.
75. D.M. Maron, B.N. Ames, Revised, methods for the Salmonella mutagenicity test, Mutat. Res. 113 (1983) 173-215. (Pubitemid 13120319)
76. T. Sugimura, Successful, use of short-term tests for academic purposes: Their use in. identification, of new environmental, carcinogens with possible risk for humans, Mutat. Res. 205 (1988) 33-39.
77. J.C. Fuscoe, R. Wu, N.H. Shen, S.K. Healy, J.S. Felton, Base-change analysis of revenants of the hisD3052 allele in Salmonella typhimurium, Mutat. Res. 201 (1988) 241-251.
78. J.S. Felton, M.G. Knize, F. A, Dolbeare, R. Wu, Mutagenic activity of heterocyclic amines in cooked foods, Environ. Health Perspect. 102 (Suppl. 6) (1994) 201-204.
79. R.W. Wu, J.D. Tucker, K.J. Sorensen, L.H. Thompson, J.S. Felton, Differential, effect of acetyltransferase expression on. The genotoxicity of heterocyclic amines in CHO cells, Mutat. Res. 390 (1997) 93-103.
80. H. Glatt, U. Pabel, W. Meinl, H. Frederiksen, H. Frandsen, E. Muckel, Bioactivation of the heterocyclic aromatic amine 2-amino-3-niethyl-9H-pyrido [2,3-b]indole (MeAalphaC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes, Carcinogenesis 25 (2004) 801-807.
81. J. Bendaly, S. Zhao, J.R. Neale, K.J. Metry, M.A. Doll, J.C. States, W.M. Pierce, Jr, D.W. Hein, 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline-induced I)NA adduct formation and mutagenesis in DNA repair-deficient Chinese hamster ovary cells expressing human cytochrome P4501A1 and rapid or slow acetylator N-acetyltransferase 2, Cancer Epidemiol, Biomarkers Prev. 16 (2007) 1503-1509.
82. K.J. Metry, S. Zhao, J.R. Neale, M.A. Doll, J.C. States, W.G. McGregor, W.M, Pierce, Jr, D.W. Hein, 2-amino-l-.methyl-6-phenylimidazo [4,5-b] pyridineinduced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2, MoI. Carcinog. 46 (2007) 553-563.
83. H. Glatt, Metabolic factors affecting the mutagenicity of heteroyclic amines, in: K. Skog, J. Alexander (Eds.), Acrylamide and Other Hazardous Compounds in Heat-Treated Foods, Woodhead Publishing Ltd., Cambridge, England, 2006, pp. 358-404.
84. P.D. Josephy, Genetically-engineered bacteria expressing human enzymes and their use in the study of mutagens and mutagenesis, Toxicology 181-182 (2002) 255-260.
85. Y. Oda, H. Yamazaki, M. Watanabe, T. Nohmi, T. Shimada, Development of high sensitive umu test system: Rapid detecton of genotoxicity of promutagenic aromatic amines by Salmonella typhimurium strain NM2009 possessing high O-acetyltransferase activity, Mutat. Res. 334 (1995) 145-156.
86. Y. Oda, P. Aryal, T. Terashita, E.M, Gillani, F.P. Guengerich, T. Shimada, Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, LBl, 2C9, 2D6, 2El, and 3A4 and human NADPH-P450 reductase and. bacterial O-acetyltransferase, Mutat. Res. 492 (2001) 81-90.
87. P.M. Morgenthaler, D. Holzhauser, Analysis of mutations induced by 2-amino-lmethyl-6-phenylimidazo[4,5-ř;]pyridine (PhIP) in human lymphoblastoid cells, Carcinogenesis, 16 (1995) 713-718.
88. A.M. Carothers, W. Yuan, B.E. Hingerty, S. Broyde, D. Grunberger, E.G. Snyderwine, Mutation and repair induced by the carcinogen 2-(hydroxyamino)-l- methyl-6-phenylimidazo[4,5-fe]pyridme (N-OH-PhIP) in. The dihydrofolate reductase gene of Chinese hamster ovary cells and conformational modeling of the dG-C8-PhIP adduct in DNA, Chem. Res. Toxicol. 7 (1994) 209-218.
89. R.W. Wu, E.M. Wu, L.H. Thompson, J.S. Felton, Identification of aprt gene mutations induced in repair-deficient and P450-expressing CHO cells by the foodrelated mutagen/carcinogen, PhIP, Carcinogenesis 16 (1995) 1207-1213.
90. M. Yadollahi-Farsani, N.J. Gooderham, D.S. Davies, A.R. Boobis, Mutational spectra of the dietary carcinogen 2-amino-l-m.ethyl-6- phenyliinidazo[4,5-//|pyridine(PhIP) at the Chinese hamsters hprt locus, Carcinogenesis 17 (1996) 617-624.
91. H. Kakiuchi, M, Watanabe, T. Ushijima, M, Toyota, K, Imai, J.H, Weisburger, T. Sugimura, N. Nagao, Specific 5'-GGGA-3' -> 5'-GGA-3' mutation, of the APC gene in rat colon, tumors induced by 2-amino-l-methyl-6- phenylimidazo[4,5-fc] pyridine, Proc. Natl, Acad. Sci. U. S. A. 92 (1995) 910-914.
92. P.M.. Leong-Morgenthaler, H. Op, V.E. Jaccaud, R.J. Turesky, Mutagenicity of 2-amino-3-methylimidazo[4,5-f]qumoline in. human lymphoblastoid cells, Carcinogenesis 19 (1998) 1749-1754.
93. R.J. Turesky, J. Bendaly, I. Yasa, M. A. Doll, D.W. Hein, The impact of NAT2 acetylator genotype on. mutagenesis and DNA adducts from 2-amino-9.H-pyrido[2,3b]indole, Chem Res. Toxicol. (2009), in press.
94. R.W. Wu, F.N. Panteleakos, J.S. Felton, Development and characterization of CHO repair-proficient cell lines for comparative mutagenicity and metabolism of heterocyclic amines from cooked food, Environ. Mol. Mutagen, 41 (2003) 7-13.
95. J.A. Gossen, W.J. de Leeuw, C.H. Tan, E.G. Zwarthoff, F. Berends, P.H. Lohman, D.L, Knook, J. Vijg, Efficient rescue of integrated, shuttle vectors from transgenic mice: A model for studying mutations in. vivo, Proc. Natl. Acad. Sci, U. S. A, 86 (1989) 7971-7975.
96. J.A, Gossen, W.J. de Leeuw, J. Vijg, LacZ transgenic mouse models: Their application in genetic toxicology, Mutat. Res. 307 (1994) 451-459.
97. S.W. Kohler, G.S. Provost, P.L. Kretz, A. Fieck, J.A. Sorge, J.M. Short, The use of transgenic mice for short-term, in vivo mutagenicity testing, Genet. Anal. Tech, Appl.' 7 (1990) 212-218.
98. J.A, Heddle, S. Dean, T. Nohmi, M. Boerrigter, D. Casciano, CR. Douglas, B.W. Glickman, NJ. Gorelick, J.C. Mirsalis, HJ. Martus, T.R. Skopek, V. Thybaud, K. R. Tindall, N. Yajima, In vivo transgenic mutation assays, Environ, Mol Mutagen. 35 (2000) 253-259.
99. H, Okonogi, T. Ushijima, X.B. Zhang, J.A. Heddle, T. Suzuki, T. Sofuni, J.S. Felton, J.D. Tucker, T. Sugimura, M. Nagao, Agreement of mutational, characteristics of heterocyclic amines in lad of the Big Blue mouse with those in tumor related genes in rodents, Carcinogenesis 18 (1997) 745-748.
100. E. Okochi, N. Watanabe, Y. Shimada, S. Takahashi, K. Wakazono, T. Shirai, T. Sugimura, M. Nagao, T. Ushijima, Preferential induction of guanine deletion at 5'-GGGA-3' in. rat mammary glands by 2-amino-l-methyl-6-phenylimidazo[4,5-b] pyridine, Carcinogenesis 20 (1999) 1933-1938.
101. T. Shirai, M, Sano, S. Tamano, S. Takahashi, M. Hirose, M, Futakuchi, R. Hasegawa, K. Imaida, K. Matsumoto, K. Wakabayashi, T. Sugimura, N. Ito, The prostate: A target for carcinogenicity of 2-a.mino-l-methyl-6-phenyliniidazo[4, 5-l>|pyridine (PhIP) derived from cooked foods, Cancer Res. 57 (1997) 195-198.
102. G.R, Stuart, J. Holcroft, J.G. de Boer, B.W. Glickman, Prostate mutations in rats induced by the suspected human carcinogen 2-amino-l-.methyl-6- phenylimidazo [4,5-%yridme, Cancer Res. 60 (2000) 266-268.
103. Y. Nakai, W.G. Nelson, A.M.. De Marzo, The dietary charred meat carcinogen 2amino-l-methyl-6-phen:ylimidazo[4,5-b]pyridin.e acts as both a tumor initiator and promoter in. The rat ventral prostate, Cancer Res. 67 (2007) 1378-1384.
104. M. Nagao, T. Ushijima, M. Toyota, R, Inoue, T. Sugimura, Genetic changes induced by heterocyclic amines, Mutat. Res. 376 (1997) 161-167.
105. M. Nagao, M, Ochiai, E. Okochi, T. Ushijima, T. Sugimura, Lad transgenic animal study: Relationships among DNA-adduct levels, mutant frequencies and cancer incidences, Mutat. Res. 477 (2001) 119-124.
106. S.A. Bol, J. Horlbeck, J. Markovic, J.G. de Boer, R.J. Turesky, A. Constable, Mutational analysis of the liver, colon and kidney of Big Blue rats treated with. 2-aniino-3-methylimidazo[4,5-/]quinoline, Carcinogenesis 21 (2000) 1-6.
107. R.A, Brooks, NJ. Gooderham", K. Zhao, R.J. Edwards, L.A. Howard, A.R. Boobis, DJ. Winton, 2-Amino-l-m.ethyl-6-phenylimidazo[4,5-/]pyridine is a potent mutagen in the mouse small, intestine, Cancer Res. 54 (1994) 1665-1671.
108. + allele, Mutagenesis 16 (2001) 309-315.
109. H. Ohgaki, H. Hasegawa, T. Kato, M, Suenaga, M. Ubukata, S. Sato, S. Takayama, T. Sugimura, Carcinogenicity in mice and rats of heterocyclic amines in. cooked foods, Environ. Health Perspect. 67 (1986) 129-134.
110. CR. Stuart, E. Thorleifson, E. Okochi, J.G. de Boer, T. Ushijima, M. Nagao, B.W. Glickman, Interpretation of mutational spectra from different genes: Analyses of PhlP-induced mutational specificity in the lad and ell transgenes from colon of Big Blue rats, Mutat. Res. 452 (2000) 101-121.
111. B.A. Diwan, K.E. Blackmail, Differential susceptibility of 3 sublines of C57BL/6 mice to the induction of colorectal tumors by 1,2-dimethylhydrazine, Cancer Lett. 9 (1980) 111-115.
112. H. Fujita, K. Nagano, M. Ochiai, T. Ushijima, T. Sugimura, M. Nagao, T. Matsushima, Difference in target organs in carcinogenesis with a heterocyclic amine, 2-arnino-3,4-dimethylimidazo[4,5-f]quinoline, in. different strains of mice, Jpn. J. CancerRes. 90 (1999) 1203-1206.
113. M. Ochiai, H. Imai, T. Sugimura, M, Nagao, H, Nakagama, Induction of intestinal tumors and lymphomas in C57BL/6N mice by a food-borne carcinogen, 2-amino-lniethy.l-6-phenylimidazo[4,5-b]pyridine, Jpn, J Cancer Res. 93 (2002) 478-483.
114. R.H. Adamson, U.P. Thorgeirsson, E.G. Snyderwine, J. Reeves, D.W. Dalgard, S. Takayama, T. Sugimura, Carcinogenicity of 2-amino-3-methylimidazo[4, 5-/]quinoline in nonhuman primates: Induction of tumors in three macaques, Jpn. J. Cancer Res. 81 (1990) 10-14.
115. M. Toyota, T. Ushijima, H. Kakiuchi, F. Canzian, M, Watanabe, K. Imai, T. Sugimura, M, Nagao, Genetic alterations in rat colon tumors induced by heterocyclic amines, Cancer 77 (1996) 1593-1597.
116. N. Nagao, K. Wakabayashi, U. Ushijima, M. Toyota, Y. Totsuka, T. Sugimura, Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in animals, Environ. Health Perspect. 104 (Suppl. 3) (1996) 497-501.
117. M. Nagao, Mutagenicity, in: M. Nagao, T. Sugimura (Eds.), Food Borne Carcinogens Heterocyclic Amines, John Wiley & Sons Ltd., Chichester, England, 2000, pp. 163-195.
118. Y. Fujimoto, L.L. Hampton, E.G. Snyderwine, M, Nagao, T. Sugimura, R.H, Adamson, S.S. Thorgeirsson, p53 gene mutation in. hepatocellular carcinoma induced by 2-amin.o-3-metliylimidazo[4,5-/]quinoline in nonhuman. primates, Jpn. J. Cancer Res. 85 (1994) 506-509.
119. S.M, Powell, N. ZiIz, Y. Beazer-Barclay, T.M, Bryan, S.R. Hamilton, S.N. Thibodeau, B. Vogelstein, K.W. Kinzler, APC mutations occur early during colorectal tumorigenesis, Nature 359 (1992) 235-237.
120. D. Burnouf, R. Miturski, M. Nagao, H. Nakagama, M. Nothisen, J. Wagner, R.P. Fuchs, Early detection, of 2-amino-l-niethyl-6-phenylimida.zo[4,5-b] pyridine(PhIP)induced mutations within the Ape gene of rat colon, Carcinogenesis 22 (2001) 329-335.
121. J. Alexander, B. Heidenreich, R. Reistad, J.A. Holme, Metabolism of the food carcinogen 2-amino-l-methyl-6-phenylimidazo[4,5-b] (PhIP) in the rat and other rodents, in: R.H. Adamson, J.-A. Gustafsson, N. Ito, M. Nagao, T. Sugimura, K. Wakabayashi, Y. Yamazoe (Eds.), Heterocyclic amines in cooked foods: Possible human carcinogens. 23rd Proceedings of the Princess Takamatusu Cancer Society, Princeton Scientific Publishing Co. Inc., NJ, 1995, pp. 59-68.
122. R.S. King, F.F. Kadlubar, R.J. Turesky, In vivo metabolism of heterocyclic amines, in: M. Nagao, T. Sugimura (Eds.), Food Borne Carcinogens: Heterocyclic Amines, John Wiley & Sons Ltd., Chichester, England, 2000, pp. 90-111.
123. Y. Yamazoe, K. Nagata, In vitro metabolism, in: T. Sugimura, M. Nagao (Eds.), Food Borne Carcinogens Heterocyclic Amines, John Wiley & Sons Ltd., Chichester, England, 2000, pp. 74-89.
124. M. Bashir, D.G. Kingston, R.J. Carman, R.L. Van Tassell, T.D. Wilkins, Anaerobic metabolism of 2-amino-3-methyl-3H-imidazo[4,5-.f]quinoline (IQ) by human fecal flora, Mutat. Res. 190 (1987) 187-190.
125. R.J. Turesky, F.P. Guengerich, A. Guillouzo, S. Langouet, Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2, Mutat. Res. 506-507 (2002), 187-195.
126. pA (P450IA2), the phenacetin. O-deethylase, is primarily responsible for the hepatic 3-deniethylation of caffeine and N-oxidation of carcinogenic arylamines, Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 7696-7700.
127. T. Shimada, F.P. Guengerich, Activation of amino-α-carboline, 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine, and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes, Cancer Res. 51 (1991) 5284-5291.
128. C. Chen, X. Ma, M.A. Malfatti, K.W. Krausz, S. Kimura, J.S. Felton, J.R. Idle, F.J. Gonzalez, A comprehensive investigation of 2-amino-l-methyl.-6- phenylimidazo [4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach, Chem. Res. Toxicol. 20 (2007) 531-542.
129. V.M. Lakshmi, F.F. Hsu, T.V. Zenser, N-Demethylation is a major route of 2-amino-3-methylimidazo[4,5-f]quinoline metabolism in mouse, Drug Metab Dispos. 36 (2008) 1143-1152.
130. E.G. Snyderwine, R.J. Turesky, K.W. Turteltaub, C.D. Davis, N. Sadrieh, H.A. Schut, M. Nagao, T. Sugimura, U.P. Thorgeirsson, R.H. Adamson, S.S. Thorgeirsson, Metabolism of food-derived heterocyclic amines in nonhuman primates, Mutat. Res. 376 (1997) 203-210.
131. S. Langouët, D.H. Weld, N. Kerriguy, L.B. Fay, T. Huynh-Ba, J. Markovic, F.P. Guengerich, A. Guillouzo, R.J. Turesky, Metabolism, of 2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimiadazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2, Chem. Res. Toxicol. 14 (2001) 211-221.
132. R.J. Turesky, R.C. Garner, D.H. Weld, J. Richoz, S.H. Leveson, K.H. Dingley, K.W. Turteltaub, L.B. Fay, Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans, Chem. Res. Toxicol. 11 (1998) 217-225.
133. K.S. Kulp, M.G. Knize, N.D. Fowler, C.P. Salmon, J.S. Felton, PhIP metabolites in human urine after consumption of well-cooked chicken, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 802 (2004) 143-153.
134. D.G. Walters, P.J. Young, C Agus, M.G. Knize, A.R. Boobis, N.J. Gooderham, B.G. Lake, Cruciferous vegetable consumption alters the metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans, Carcinogenesis 25 (2004) 1659-1669.
135. J.M. Fede, A.P. Thakur, N.J. Gooderham, R.J. Turesky, Biomonitoring of 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its carcinogenic metabolites in urine, Chem. Res. Toxicol. 22 (2009) 1096-1105.
136. P.I. Mackenzie, K.W. Bock, B. Burchell, C. Guillemette, S. Ikushiro, T. Iyanagi, J.O. Miners, I.S. Owens, D.W. Nebert, Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily, Pharmacogenet. Genomics 15 (2005) 677-685.
137. S.A. Nowell, J.S. Massengill, S. Williams, A. Radominska-Pandya, T.R. Tephly, Z. Cheng, C.P. Strassburg, R.H. Tukey, S.L. MacLeod, N.P. Lang, F.F. Kadlubar, Glucuronidation of 2-hydroxyamino-l-methyl-6-phenylimidazo[4,5-b] pyridine by human microsomal UDP-glucuronosyltransferases: Identification of specific UGT1A family isoforms involved, Carcinogenesis 20 (1999) 1107-1114.
138. M.A. Malfatti, J.S. Felton, Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro, Chem. Res. Toxicol. 17 (2004) 1137-1144.
139. R.W. Dellinger, G. Chen, A.S. Blevins-Prinieau, J. Krzeminski, S. Amin, P. Lazarus, Glucuronidation of PhIP and N-OH-PhIP by UDP-glucuronosyltransferase 1A10, Carcinogenesis 28 (2007) 2412-2418.
140. P.B. Styczynski, R.C. Blackmon, J.D. Groopman, T.W. Kensler, The direct glucuronidation of 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human and rabbit liver microsomes, Chem. Res. Toxicol. 6 (1993) 846-851.
141. S. Langouët, A. Paehler, D.H. Welti, N. Kerriguy, A. Guillouzo, R.J. Turesky, Differential metabolism of 2-amino-l-methyl-6-phenylimidazo[4,5- b]pyridine in rat and human hepatocytes, Carcinogenesis 23 (2002) 115-122.
142. H. Girard, J. Thibaudeau, M.H. Court, L.C. Fortier, L. Villeneuve, P. Caron, Q. Hao, L.L. von Moltke, D.J. Greenblatt, C. Guillemette, UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver, Hepatology 42 (2005) 448-457.
143. C.P. Strassburg, A. Vogel, S. Kneip, R.H. Tukey, M.P. Manns, Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer, Gut 50 (2002) 851-856.
144. M.A. Malfatti, K.H. Dingley, S. Noweli-Kadlubar, E.A. Ubick, N. Mulakken, D. Nelson, N.P. Lang, J.S. Felton, K.W. Turteltaub, The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]
145. 2 -oxidized species of 2-amino-1-methyl-6-phenylimidazo[4,5-b] (PhIP) in rat liver, Carcinogenesis 12 (1991) 2239-2245.
146. K.R. Kaderlik, G.J. Mulder, R.J. Turesky, N.P. Lang, C.H. Teitel, M.P. Chiarelli, F.F. Kadlubar, Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes, Carcinogenesis 15 (1994) 1701.
147. D.W. Hein, M.A. Doll, A.J. Fretland, M.A. Leff, S.J. Webb, G.H. Xiao, U.S. Devanaboyina, N.A. Nangju, Y. Feng, Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms, Cancer Epidemiol. Biomarkers Prev. 9 (2000) 29-42.
148. D.W. Hein, Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis, Mutat. Res. 506-507 (2002) 65-77.
149. R.F. Minchin, P.T. Reeves, C.H. Teitel, M.E. McManus, B. Mojarrabi, K.F. Ilett, F.F. Kadlubar, N- and O-acetylation of aromatic and hetercyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells, Biochem. Biophys. Res. Commun. 185 (1992) 839-844.
150. R.J. Turesky, N.P. Lang, M.A. Butler, C.H. Teitel, F.F. Kadlubar, Metabolicactivation of carcinogenic heterocyclic aromatic amines by human liver and colon, Carcinogenesis 12 (1991) 1839-1845.
151. R.S. King, C.H. Teitel, F.F. Kadlubar, In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline, Carcinogenesis 21 (2000) 1347-1354.
152. R.L. Blanchard, R.R. Freimuth, J. Buck, R.M. Weinshilboum, M.W. Coughtrie, A proposed nomenclature system for the cytosolic sulfotransfera.se (SULT) superfamily, Pharmacogenetics 14 (2004) 199-211.
153. S. Nowell, C.N. Falany, Pharmacogenetics of human cytosolic sulfotransferases, Oncogene 25 (2006) 1673-1678.
154. S. Ozawa, K. Nagata, Y. Yamazoe, R. Kato, Formation of 2-amino-3-methylimidazo[4,5-f]quinoline- and 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline-sulfamates by cDNA-expressed mammalian phenol sulfotransferases, Jpn. J. Cancer Res. 86 (1995) 264-269.
155. A.J. Lewis, U.K. Walle, R.S. King, F.F. Kadlubar, C.N. Falany, T. Walle, Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6- phenylmiidazo [4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells, Carcinogenesis 19 (1998) 2049-2053.
156. M. Tsuda, C. Negishi, R. Makino, S. Sato, Z. Yamaizumi, T. Hirayama, T. Sugimura, Use of nitrite and hypochlorite treatments in determination of the contributions of IQ-type and non-IQ-type heterocyclic amines to the mutagenicities in crude pyrolyzed materials, Mutat. Res. 147 (1985) 335-341.
157. V.M. Lakshmi, H.A. Schut, T.V. Zenser, 2-Nitrosoamino-3-methylimidazo[4, 5-f] quinoline activated by the inflammatory response forms nucleotide adducts, Food Chem. Toxicol. 43 (2005) 1607-1617.
158. V.M. Lakshmi, M.L. Clapper, W.C Chang, T.V. Zenser, Hemin potentiates nitric oxide-mediated nitrosation of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) to 2-nitrosoamino-3-methylimidazo[4,5-f]quinoline, Chem. Res. Toxicol. 18 (2005) 528-535.
159. T.V. Zenser, V.M. Lakshmi, H.A. Schut, H.J. Zhou, P.D. Josephy, Activation of aminoimidazole carcinogens by nitrosation: mutagenicity and nucleotide adducts, Mutat. Res. 673 (2009) 109-115.
160. R.J. Turesky, The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines, Curr. Drug Metab. 5 (2004) 169-180.
161. D.L. Eaton, E.P. Gallagher, T.K. Bammler, K.L. Kunze, Role of cytochrome P450 1A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity, Pharmacogenetics 5 (1995) 259-274.
162. C. Belloc, S. Baird, J. Cosme, S. Lecoeur, J.-C. Gautier, D. Challine, I. de Waziers, J.-P. Flinois, P.H. Beaune, Human cytochrome P450 expressed in Escherichia coli: Production of specific antibodies, Toxicology 106 (1996) 207-219.
163. A.H. Conney, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture, Cancer Res. 42 (1982) 4875-4917.
164. G.J. Hammons, Y. Yan-Sanders, B. Jin, E. Blann, F.F. Kadlubar, B.D. Lyn-Cook, Specific site methylation in the 5′-flanking region of CYP1A2 interindividual differences in human livers, Life Sci. 69 (2001) 839-845.
165. M. Nakajima, T. Yokoi, M. Mizutani, M. Kinoshita, M. Funayama, T. Kamataki, Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans, J. Biochem. (Tokyo) 125 (1999) 803-808.
166. C. Sachse, U. Bhambra, G. Smith, T.J. Lightfoot, J.H. Barrett, J. Scollay, R.C. Garner, A.R. Boobis, C.R. Wolf, N.J. Gooderham, Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls:Allele frequencies, linkage disequilibrium and influence on caffeine metabolism, Br. J. Clin. Pharmacol. 55 (2003) 68-76.
167. Z. Jiang, N. Dragin, L.F. Jorge-Nebert, M.V. Martin, F.P. Guengerich, E. Aklillu, M. Ingelman-Sundberg, G.J. Hammons, B.D. Lyn-Cook, F.F. Kadlubar, S.N. Saldana, M. Sorter, A.A. Vinks, N. Nassr, R.O. von, L. Jin, D.W. Nebert, Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype, Pharmacogenet. Genomics 16 (2006) 359-367.
168. D.W. Hein, N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk, Oncogene 25 (2006) 1649-1658.
169. M. Garcia-Closas, N. Malats, D. Silverman, M. Dosemeci, M. Kogevinas, D.W. Hein, A. Tardon, C. Serra, A. Carrato, R. Garcia-Closas, J. Lloreta, G. CastanoVinyals, M. Yeager, R. Welch, S. Chanock, N. Chatterjee, S. Wacholder, C. Samanic, M. Tora, F. Fernandez, F.X. Real, N. Rothman, NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses, Lancet 366 (2005) 649-659.
170. E. Giovannucci, An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer, Cancer Epidemiol. Biomarkers Prev. 10 (2001) 725-731.
171. N.P. Lang, M.A. Butler, J.P. Massengill, M. Lawson, R.C. Stotts, M. Hauer-Jensen, F.F. Kadlubar, Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps, Cancer Epidemiol. Biomarkers Prev. 3 (1994) 675-682.
172. L. Le Marchand, J.H. Hankin, L.M. Pierce, R. Sinha, P.V. Nerurkar, A.A. Franke, L.R. Wilkens, L.N. Kolonel, T. Donlon, A. Seifried, L.J. Custer, A. Lum-Jones, W. Chang, Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii, Mutat. Res. 506-507 (2002) 205-214.
173. X.B. Zhang, J.S. Felton, J.D. Tucker, C. Urlando, J.A. Heddle, Intestinal mutagenicity of two carcinogenic food mutagens in transgenic mice: 2-amnio-l-methyl-6-phenylimidazo[4,5-b]pyridine and amino (alpha) carboline, Carcinogenesis 17 (1996) 2259-2265.
174. H. Okonogi, T. Ushijima, H. Shimizu, T. Sugimura, M. Nagao, Induction of aberrant crypt foci in C57BL/6N mice by 2-amino-9H-pyrido[2,3-b]indole (A alphaC) and 2-amino-3,8-dimethyhmidazo[4,5-f]quinoxaline (MeIQx), Cancer Lett. 111 (1997) 105-109.
175. R.B. Raftogianis, T.C. Wood, R.M. Weinshilboum, Human phenol sulfotransferases SULT1A2 and SULT1A1: Genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations, Biochem. Pharmacol. 58 (1999) 605-616.
176. W. Zheng, D. Xie, J.R. Cerhan, T.A. Sellers, W. Wen, A.R. Folsom, Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk, Cancer Epidemiol. Biomarkers Prev. 10 (2001) 89-94.
177. S. Nowell, C.B. Ambrosone, S. Ozawa, S.L. MacLeod, G. Mrackova, S. Williams, J. Plaxco, F.F. Kadlubar, N.P. Lang, Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol, Pharmacogenetics 10 (2000) 789-797.
178. V. Moreno, H. Glatt, E. Guino, E. Fisher, W. Meinl, M. Navarro, J.M. Badosa, H. Boeing, Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer, Int. J. Cancer 113 (2005) 683-686.
179. M. Steiner, M. Bastian, W.A. Schulz, T. Pulte, K.H. Franke, A. Rohring, J.M. Wolff, H. Seiter, P. Schuff-Werner, Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association, Arch. Toxicol. 74 (2000) 222-225.
180. S.S. Hecht, Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer, Carcinogenesis 23 (2002) 907-922.
181. U. Peters, D.M. DeMarini, R. Sinha, L.R. Brooks, S.H. Warren, N. Chatterjee, N. Rothman, Urinary mutagenicity and colorectal adenoma risk, Cancer Epidemiol. Biomarkers Prev. 12 (2003) 1253-1256.
182. D.S. Wishart, D. Tzur, C. Knox, R. Eisner, A.C. Guo, N. Young, D. Cheng, K. Jewell, D. Arndt, S. Sawhuey, C. Fung, L. Nikolai, M. Lewis, M.A. Coutouly, I. Forsythe, P. Tang, S. Shrivastava, K. Jeroncic, P. Stothard, G. Amegbey, D. Block, D.D. Hau, J. Wagner, J. Miniaci, M, Clements, M, Gebremedhin, N. Guo, Y. Zhang, G.E. Duggan, G.D. Macinnis, A.M. Weljie, R. Dowlatabadi, F. Bamforth, D. Clive, R. Greiner, L. Li, T. Marrie, B.D. Sykes, H.J. Vogel, L. Querengesser, HMDB: The Human Metabolome Database, Nucleic Acids Res. 35 (2007) D521-D526.
183. A.R. Boobis, A.M. Lynch, S. Murray, R. de la Torre, A. Solans, M. Farré, J. Segura, N.J. Gooderham, D.S. Davies, CYPlA2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans, Cancer Res. 54(1994) 89-94.
184. J. Alexander, R, Reistad, S. Hegstad, H. Frandsen, K. Ingebrigtsen, J.E. Paulsen, G. Becher, Biomarkers of exposure to heterocyclic amines: Approaches to improve the exposure assessment, Food Chem. Toxicol. 40 (2002) 1131-1137.
185. R.D. Holland, J. Taylor, L. Schoenbachler, R.C. Jones, J.P. Freeman, D.W. Miller, B.G. Lake, N.J. Gooderham, R.J. Turesky, Rapid biomonitoring of heterocyclic aromatic amines in human urine by tandem solvent solid phase extraction liquid chromatography electrospray ionization mass spectrometry, Chem. Res. Toxicol, 17 (2004) 1121-1136.
186. H. Frandsen, Biomonitoring of urinary metabolites of 2-arnino-l-methyl-6- phenylimidazo[4, 5-b]pyridine (PhIP) following human consumption of cooked chicken, Food Chem. Toxicol. 46 (2008) 3200-3205.
187. W.G. Stillwell, L.-C.K.S.-B. Kidd, J.W. Wishnok, S.R. Tannenbaum, R. Sinha, Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6phenylimidazo[4, 5-b] pyridine and 2-amino-3, 8-diniethylimidazo[4, 5-f] quinoxaline in humans: Relationship to cytochrome P450 1A2 and N-acetyltransferase activity, Cancer Res. 57 (1997) 3457-3464.
188. W.G. Stillwell, R.J. Turesky, R. Sinha, P.L. Skipper, S.R. Tannenbaum, Biomonitoring of heterocyclic aromatic amine metabolites in human urine, Cancer Lett. 143 (1999) 145-148.
189. P.T. Strickland, Z. Qian, M.D. Friesen, N. Rothman, R. Sinha, Metabolites of 2-amino-l-methyl-6-phenylimidazo [4, 5-b] pyridme (PhIP) in human urine after consumption of charbroiled or fried beef, Mutat. Res. 506-507 (2002) 163-173.
190. H. Frandsen, Deconjugation of N-glucuronide conjugated metabolites with hydrazine hydrate-biomarkers for exposure to the food-borne carcinogen 2-amino-l-methyl-6phenylimidazo[4, 5-b] pyridine (PhIP), Food Chem Toxicol.45 (2007) 863-870.
191. W.G. Stillwell, R. Sinha, S.R. Tannenbaum, Excretion of the N(2)-glucuronide conjugate of 2-hydroxyanmino-l-methyl-6-phenylimidazo[4, 5-b]pyridine in urine and its relationship to CYP1A2 and NAT2 activity levels in humans, Carcinogenesis 23 (2002) 831-838.
192. W.G. Stillwell, R.J. Turesky, G.A. Gross, P.L. Skipper, S.R. Tannenbaum, Human urinary excretion of sulfamate and glucuronde conjugates of 2-amino-3, 8-dimethylinidazo[4, 5-f] quinoxaline (MeIQx), Cancer Epidemiol. Biomarkers Prev. 3 (1994) 399-405.
193. R. Sinha, N. Rothman, S.D. Mark, S. Murray, E.D. Brown, O.A. Levander, D.S. Davies, N.P. Lang, F.F. Kadlubar, R.N. Hoover, Lower levels of urinary 2-amino3, 8-dimethylimidazo [4, 5-f]-quinoxaline (MeIQx) in humans with higher CYP1A2 activity, Carcinogenesis 16 (1995) 2859-2861.
194. K.L. Kunze, W.F. Trager, Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline, Chem. Res. Toxicol. 6 (1993) 649-656.
195. R.J. Turesky, V. Parisod, T. Huynh-Ba, S. Langouet, F.P. Guengerich, Regioselective differences in C(8)- and N-oxidation of 2-amino-3, 8- dimethylimidazo[4, 5-f] quinoxaline by human and rat liver microsomes and cytochromes P450 1A2, Chem. Res. Toxicol. 14 (2001) 901-911.
196. L.C. Kidd, W.G. Stillwell, M.C. Yu, J.S. Wishnok, P.L. Skipper, R.K. Ross, B.E. Henderson, S.R. Tannenbaum, Urinary excretion of 2-amino-l-niethyl-6- phenylimidazo[4, 5-b]pyridine (PhIP) in White, African-American, and Asian-American men in Los Angeles County, Cancer Epidemiol. Biomarkers Prev. 8 (1999) 439-445.
197. 2 -glucuronide conjugate of 2-hydroxyamino-MeIQx in urine, Cancer Res. 59 (1999) 5154-5159.
198. K.W. Turteltaub, R.J. Mauthe, K.H. Dingley, J.S. Vogel, C.E. Frantz, R.C. Garner, N. Shen, MeIQx-DNA adduct formation in rodent and human tissues at low doses, Mutat. Res. 376 (1997) 243-252.
199. K.H. Dingley, K.D. Curtis, S. Nowell, J.S. Felton, N.P. Lang, K.W. Turteltaub, DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-l-methyl-6-phenylimidazo[4, 5-b] pyridine, Cancer Epidemiol. Biomarkers Prev. 8 (1999) 507-512.
200. C. Magagnotti, R. Pastorelli, S. Pozzi, B. Andreoni, R. Fanelli, L. Airoldi, Genetic polymorphisms and modulation of 2-amino-l-niethyl-6- phenylimidazo[4, 5-b]pyridine (PhIP)-DNA adducts in human lymphocytes, Int. J Cancer 1.07 (2003) 878-884.
201. K.W. Turteltaub, K.H. Dingley, K.D. Curtis, M.A. Malfatti, R.J. Turesky, R.C. Gamer, J.S. Felton, N.P. Lang, Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses, Cancer Lett. 143 (1999) 149-155.
202. T.J. Lightfoot, J.M. Coxhead, B.C. Cupid, S. Nicholson, R.C. Garner, Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration, of 2-amino-l-methyl-6-phenylimidazo[4, 5-b]pyridine and benzo[a]pyrene, Mutat. Res. 472 (2000) 119-127.
203. 2 -(deoxyguanosin-8-yl)-2-amino-3, 8-dimethylimidazo[4, 5/]quinoxaline (dG-C8-MeIQx) in human tissues, Carcinogenesis 17 (1996) 1029-1034.
204. 32 P-postlabeling, Chem. Res. Toxicol. 7 (1994) 733-739.
205. D.-X. Lin, D.J. Meyer, B. Ketterer, N.P. Lang, F.F. Kadlubar, Effects of human and rat glutathione-S-transferase on the covalent binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: A possible mechanism of organ specificity in their carcinogensis, Cancer Res. 54 (1994) 4920-4926.
206. B.F. Coles, F.F. Kadlubar, Detoxification of electrophilic compounds by glutathione S-transferase catalysis: Determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 17 (2003) 115-130.
207. J. Zhu, P. Chang, M.L. Bondy, A.A. Sahin, S.E. Singletary, S. Takahashi, T. Shirai, D. Li, Detection of 2-amino-l-methyl-6-phenylimidazo[4, 5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer, Cancer Epidemiol. Biomarkers Prev. 12 (2003) 830-837.
208. K. Gorlewska-Roberts, B. Green, M. Fares, C.B. Ambrosone, F.F. Kadlubar, Carcinogen-DNA adducts in human breast epithelial cells, Environ. Mol. Mutagen, 39 (2002) 184-192. (Pubitemid 34260492)
209. D. Tang, J.J. Liu, A. Rundle, C. Neslund-Dudas, A.T. Savera, C.H. Bock, N.L. Nock, J.J. Yang, B.A. Rybicki, Grilled meat consumption and PhIP-DNA adducts in prostate carcinogenesis, Cancer Epidemiol. Biomarkers Prev. 16 (2007) 803-808.
210. R. Singh, P.B. Farmer, Liquid chroniatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection, Carcinogenesis 27 (2006) 178-196.
211. E.M. Ricicki, J.R. Soglia, C. Teitel, R. Kane, F. Kadlubar, P. Vouros, Detection and quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human, pancreas tissue using capillary liquid chromatography- microelectrospray mass spectrometry, Chem Res. Toxicol. 18 (2005) 692-699.
212. F.A. Beland, M.I. Churchwell, L.S. Von Tungeln, S. Chen, P.P. Fu, S.J. Gulp, B. Schoket, E. Gyorffy, J. Minarovits, M.C. Poirier, E.D. Bowman, A. Weston, D.R. Doerge, High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts, Chem. Res. Toxicol. 18 (2005) 1306-1315. (Pubitemid 41170255)
213. A.P. Grollman, S. Shibutani, M. Moriya, F. Miller, L. Wu, U. Moll, N. Suzuki, A. Fernandes, T. Rosenquist, Z. Medverec, K. Jakovina, B. Brdar, N. Slade, R.J. Turesky, A.K. Goodenough, R. Rieger, M. Vukelic, B. Jelakovic, Aristolochic acid and the etiology of enderme (Balkan) nephropathy, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 12129-12134. (Pubitemid 47185641)
214. L. Chen, M. Wang, P.W. Villalta, X. Luo, R. Feuer, J. Jensen, O.K. Hatsukami, S.S. Hecht, Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation, Chem. Res. Toxicol. 20 (2007) 108-113.
215. P.L.. Skipper, X. Peng, C.K. SooHoo, S.R. Tannenbaum, Protein adducts as biomarkers of human carcinogen exposure, Drug Metab. Rev. 26 (1994) 111-124.
216. K.H. Dingley, S.P. Freeman, D.O. Nelson, R.C. Garner, K.W. Turteltaub, Covalent binding of 2-amino-3, 8-dimethylimidazo[4, 5-f] quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats, Drug Metab. Dispos. 26 (1998) 825-828.
217. T. Peters, Jr, All about Albumin. Biochemistry, Genetics, and Medical applications, Academic Press, San Diego, 1996.
218. S. Carballal, R. Radi, M.C. Kirk, S. Barnes, B.A. Freeman, B. Alvarez, Sulfonic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite, Biochemistry 42 (2003) 9906-9914.
219. J.L. Beck, S. Ambahera, S.R. Yong, M.M. Sheil, J.J. de, S.F. Ralph, Direct observation of covalent adducts with Cys34 of human serum albumin using mass spectrometry, Anal, Biochem. 325 (2004) 326-336.
220. J.F. Keaney, Jr, D.I. Simon, J.S. Stamler, O. Jaraki, J. Scharfstein, J.A. Vita, J. Loscalzo, NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties, J. Clin, Invest. 91 (1993) 1582-1589.
221. R.J. Turesky, P.L. Skipper, S.R. Tannenbaum, Binding of 2-amino-3-methylimidazo[4,5-f]quinoline to hemoglobin and alubmin in the rat. Identificaiton of an adduct suitable for dosimetry, Carcinogenesis 8 (1987) 1537-1542.
222. A.M. Lynch, S. Murray, K. Zhao, N.J. Gooderham, A.R. Boobis, D.S. Davies, Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin, Carcinogenesis 14 (1993) 191-194.
223. R. Reistad, H. Frandsen, S. Grivas, J. Alexander, In vitro formation and degradation of 2-amino-1-methyl-6- phenylimidazo[4, 5-b]pyridine (PhIP) protein adducts, Carcinogenesis 15 (1994) 2547-2552.
224. C.L. Chepanoske, K. Brown, K.W. Turteltaub, K.H. Dingley, Characterization of a peptide adduct formed by N-acetoxy-2-amino-l-methyl-6- phenylimidazo[4, 5-b] pyridine (PhIP), a reactive intermediate of the food carcinogen PhIP, Food Chem Toxicol. 42 (2004) 1367-1372.
225. D. Noort, A. Fidder, A. G. Hulst, Modification of human serum albumin by acrylamide at cysteine-34: A basis for a rapid biomonitoring procedure, Arch, Toxicol. 77 (2003) 543-545.
226. D. Noort, A.G. Hulst, L.P. de Jong, H.P. Benschop, Alkylation of human serum albumin by sulfur mustard in vitro and in vivo: Mass spectrometric analysis of a cysteine adduct as a sensitive biomarker of exposure, Chem. Res. Toxicol, 12 (1999) 715-721.
227. W.E. Bechtold, J.K. Willis, J.D. Sun, W.C. Griffith, T.V. Reddy, Biological marken of exposure to benzene: S-phenylcysteine in albumin, Carcinogenesis 13 (1992) 1217-1220.
228. K.J. Hoffmann, A.J. Streeter, D.B. Axworthy, T.A. Baillie, Structural characterization of the major covalent adduct formed in vitro between acetaminophen and bovine serum albumin, Chem. Biol. Interact. 53 (1985) 155-172. (Pubitemid 15066801)
229. D. Kim, F.F. Kadlubar, C.H. Teitel, F.P. Guengerich, Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylaminie, Chem. Res. Toxicol. 17 (2004) 529-536.
230. C. Magagnotti, F. Orsi, R. Bagnati, N. Celli, D. Rotilio, R. Fanelli, L. Airoldi, Effect of diet on serum albumin and hemoglobin adducts of 2-amino-l-niethyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in humans, Int. J. Cancer 88 (2000) 1-6.
231. R.L. DuPont, W.A. Baumgartner, Drug testing by urine and hair analysis: Complementary features and scientific issues, Forensic Sci, Int. 70 (1995) 63-76.
232. Y. Nakahara, K. Takahashi, R. Kikura, Hair analysis for drugs of abuse. X. Effect of physicochemical properties of drugs on the incorporation rates into hair, Biol. Pharm. Bull, 18 (1995) 1223-1227.
233. S. Hegstad, R. Reistad, L.S. Haug, J. Alexander, Eumelanin is a major determinant for 2-amino-l-niethyl-6-phenylimidazo[4, 5-b] pyridine (PhIP) incorporation into hair of mice, Pharmacol. Toxicol. 90 (2002) 333-337.
234. H. Hashimoto, T. Hanaoka, M. Kobayashi, S. Tsugane, Analytical method of 2-anino-l-methyl-6-phenylimidazo[4, 5-b]pyridine in human hair by columnswitching liquid chromatography-mass spectrometry, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 803 (2004) 209-213.
235. M. Kobayashi, T. Hanaoka, H. Hashimoto, S. Tsugane, 2-Amino-l-methyl-6- phenylimidazo[4, 5-b]pyridine (PhIP) level in human hair as biomarkers for dietary grilled/stir-fried meat and fish intake, Mutat. Res.588 (2005) 136-142.
236. R. Reistad, S.H. Nyholm, L.S. Huag, G. Becher, J. Alexander, 2-Amino-l-methyl-6-phenylimidazo[4, 5-b] pyridine (PhIP) in human hair as biomarker for dietary exposure, Biomarkers, 4 (1999) 263-271,
237. E.E. Bessette, I. Yasa, D. Dunbar, L. Wilkens, L. Le Marchand, R.J. Turesky, Biomonitoring of carcinogenic heterocyclic aromatic amines in hair: a validation assay. Chem. Res. Toxic. 22 (2009) 1454-1463.
238. J.S. Felton, M.G. Knize, L.M. Bennett, M.A. Malfatti, M.E. Colvin, K.S. Kulp, Impact of environmental exposures on the mutagenicity/carcinogenicity of heterocyclic amines, Toxicology 198 (2004) 135-145.
239. W. Ni, L. McNaughton, D.M. LeMaster, R. Sinha, R.J. Turesky, Quantitation of 13 heterocyclic aromatic amines in cooked beef, pork, and chicken by liquid chromatography-electrospray ionization/tandem mass spectrometry, J. Agric. Food Chem. 56 (2008) 68-78.
240. S. Manabe, N. Kurihara, O. Wada, K. Tohyama, T. Aramaki, Formation of PhIP in a mixture of creatinine, phenylalanine and sugar or aldehyde by aqueous heating, Carcinogenesis 13 (1992) 827-830.
241. S. Manabe, H. Suzuki, O. Wada, A. Ueki, Detection of the carcinogen 2-amino-lmethyl-6-phenylimidazo[4, 5-b)]pyridine (PhIP) in beer and wine, Carcinogenesis 14 (1993) 899-901.
242. S. Hegstad, R. Reistad, L.S. Haug, J. Alexander, Eumelanin is a major determinant for 2-amino-l-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) incorporation into hair of mice, Pharmacol. Toxicol. 90 (2002) 333-337.
243. H. Ozeki, S. Ito, K. Wakamatsu, A.J. Thody, Spectrophotometric characterization of eumelanin and pbeomelanin in hair, Pigment Cell Res. 9 (1996) 265-270.